Kynam Capital Management, LP Dynavax Technologies Corp Transaction History
Kynam Capital Management, LP
- $1.58 Billion
- Q4 2024
A detailed history of Kynam Capital Management, LP transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Kynam Capital Management, LP holds 6,560,835 shares of DVAX stock, worth $87.5 Million. This represents 5.31% of its overall portfolio holdings.
Number of Shares
6,560,835
Previous 8,332,687
21.26%
Holding current value
$87.5 Million
Previous $92.8 Million
9.74%
% of portfolio
5.31%
Previous 7.62%
Shares
6 transactions
Others Institutions Holding DVAX
# of Institutions
288Shares Held
131MCall Options Held
507KPut Options Held
374K-
Black Rock Inc. New York, NY21.9MShares$292 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$237 Million10.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$122 Million0.0% of portfolio
-
State Street Corp Boston, MA7.79MShares$104 Million0.0% of portfolio
-
Chicago Capital, LLC5.38MShares$71.7 Million1.84% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.69B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...